146 related articles for article (PubMed ID: 18675482)
1. Developing therapeutic proteins by engineering ligand-receptor interactions.
Jones DS; Silverman AP; Cochran JR
Trends Biotechnol; 2008 Sep; 26(9):498-505. PubMed ID: 18675482
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
3. Rational design and protein engineering of growth factors for regenerative medicine and tissue engineering.
Moss AJ; Sharma S; Brindle NP
Biochem Soc Trans; 2009 Aug; 37(Pt 4):717-21. PubMed ID: 19614582
[TBL] [Abstract][Full Text] [Related]
4. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
Gerngross TU
Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
[TBL] [Abstract][Full Text] [Related]
5. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways.
Haarmann-Stemmann T; Bothe H; Abel J
Biochem Pharmacol; 2009 Feb; 77(4):508-20. PubMed ID: 18848820
[TBL] [Abstract][Full Text] [Related]
6. Disruption of protein-protein interactions: towards new targets for chemotherapy.
Loregian A; Palù G
J Cell Physiol; 2005 Sep; 204(3):750-62. PubMed ID: 15880642
[TBL] [Abstract][Full Text] [Related]
7. Periplasmic binding proteins: a versatile superfamily for protein engineering.
Dwyer MA; Hellinga HW
Curr Opin Struct Biol; 2004 Aug; 14(4):495-504. PubMed ID: 15313245
[TBL] [Abstract][Full Text] [Related]
8. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of natural product signal transduction agents.
Koehn FE
Curr Opin Biotechnol; 2006 Dec; 17(6):631-7. PubMed ID: 17049224
[TBL] [Abstract][Full Text] [Related]
10. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
[TBL] [Abstract][Full Text] [Related]
11. Functional mimetics of neurotrophins and their receptors.
Peleshok J; Saragovi HU
Biochem Soc Trans; 2006 Aug; 34(Pt 4):612-7. PubMed ID: 16856874
[TBL] [Abstract][Full Text] [Related]
12. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin signaling: progress made and promises ahead.
Zhou Y; Gunput RA; Pasterkamp RJ
Trends Biochem Sci; 2008 Apr; 33(4):161-70. PubMed ID: 18374575
[TBL] [Abstract][Full Text] [Related]
14. Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFbeta signaling.
Gomez-Duran A; Carvajal-Gonzalez JM; Mulero-Navarro S; Santiago-Josefat B; Puga A; Fernandez-Salguero PM
Biochem Pharmacol; 2009 Feb; 77(4):700-12. PubMed ID: 18812170
[TBL] [Abstract][Full Text] [Related]
15. Designing peptide receptor agonists and antagonists.
Hruby VJ
Nat Rev Drug Discov; 2002 Nov; 1(11):847-58. PubMed ID: 12415245
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cell proliferation by NADPH oxidase-mediated signaling: potential roles in tissue repair, regenerative medicine and tissue engineering.
Chan EC; Jiang F; Peshavariya HM; Dusting GJ
Pharmacol Ther; 2009 May; 122(2):97-108. PubMed ID: 19285105
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?
Oesch S; Gertsch J
J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225
[TBL] [Abstract][Full Text] [Related]
18. Engineered systems for detection and discovery of nuclear hormone-like compounds.
Gillies AR; Skretas G; Wood DW
Biotechnol Prog; 2008; 24(1):8-16. PubMed ID: 18081307
[TBL] [Abstract][Full Text] [Related]
19. IFNgamma signaling-does it mean JAK-STAT?
Gough DJ; Levy DE; Johnstone RW; Clarke CJ
Cytokine Growth Factor Rev; 2008; 19(5-6):383-94. PubMed ID: 18929502
[TBL] [Abstract][Full Text] [Related]
20. Engineered proteins as specific binding reagents.
Binz HK; Plückthun A
Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
